Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Electroacupuncture and NGF for Dysphagia After Ischemic Stroke
NCT06737549Phase 4Recruiting
- Sponsor
- Third Affiliated Hospital of Zhejiang Chinese Medical University
- Start
- Dec 2024
- Primary completion
- Dec 2027
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Nerve growth factor in dysphagia (4 arms), sponsored by Third Affiliated Hospital of Zhejiang Chinese Medical University. Primary endpoint: Functional Oral Intake Scale at 12 weeks. Started Dec 2024; status: recruiting.
02
Drugs
Nerve growth factor
03
Conditions
dysphagia
Beyond the preview
Go deeper on NCT06737549.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06737549.